TNFRSF11A and hyperphosphatemia: Additionally, hyperphosphatemia stimulates the production of parathyroid hormone (PTH), which is the primary regulator of the Receptor Activator of Nuclear Factor kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system [5,6,7].